Ube (UBEOF) Change In Payables And Accrued Expense: $0 Mil (TTM As of Mar. 2026)


UBEOF Ube Corp UBEOF
59 GF Score
Price $15.29
GF Value $11.18
! 10 Warning Signs
View Full Analysis

What is Ube Change In Payables And Accrued Expense?

Ube UBEOF 59 Change In Payables And Accrued Expense is $0 Mil as of Mar. 2026. GuruFocus rates UBEOF with a GF Score™ of 59/100 and a GF Value™ of $11.18. The stock has 10 warning signs investors should review.

Ube's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2026 was $0 Mil. It means Ube's Accounts Payable & Accrued Expense stayed the same from Dec. 2025 to Mar. 2026 .

Ube's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2026 was $0 Mil. It means Ube's Accounts Payable & Accrued Expense stayed the same from Mar. 2025 to Mar. 2026 .

Ube Change In Payables And Accrued Expense Historical Data

* Premium members only.

The historical data trend for Ube's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ube Change In Payables And Accrued Expense Chart

Ube Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ube Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
UBEOF
59GF Score
Ube Corp UBEOF
Change In Payables And Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ube Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Change In Payables And Accrued Expense of $0 Mil mean?
Ube (UBEOF) has a Change In Payables And Accrued Expense of $0 Mil as of Mar. 2026. Change In Payables And Accrued Expense is any increase or decrease between periods of the payables and accrued expense. View historical data on Ube and its competitors.
Is Ube's Change In Payables And Accrued Expense too high?
Ube's current Change In Payables And Accrued Expense is $0 Mil. Overall, Ube has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Ube's Change In Payables And Accrued Expense compare to LIN and SHW?
Ube's Change In Payables And Accrued Expense of $0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Payables And Accrued Expense for a Chemicals company?
A good Change In Payables And Accrued Expense depends on the Chemicals industry context. However, Change In Payables And Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Payables And Accrued Expense mean?
A high Change In Payables And Accrued Expense can signal that a stock is expensive relative to its fundamentals. Change In Payables And Accrued Expense is any increase or decrease between periods of the payables and accrued expense. View historical data on Ube and its competitors. Ube's current Change In Payables And Accrued Expense is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ube stock overvalued right now?
Ube (UBEOF) has a current Change In Payables And Accrued Expense of $0 Mil. The stock's GF Value™ is $11.18, compared to a current price of $15.29 — trading 36.7% above its estimated fair value. The current Change In Payables And Accrued Expense is $0 Mil. Ube's overall GF Score™ is 59/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Payables And Accrued Expense calculated?
Change In Payables And Accrued Expense is calculated from a company's financial statements. For Ube (UBEOF), the current Change In Payables And Accrued Expense is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ube (UBEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Ube stock appears to be overvalued. The current stock price of $15.29 is trading 36.7% above its estimated GF Value™ of $11.18.

Key valuation signals for UBEOF:

  • Change In Payables And Accrued Expense: $0 Mil
  • GF Value™: $11.18 vs. price of $15.29 (36.7% above fair value)
  • GF Score™: 59/100 with 10 warning signs

No single metric tells the full story. See the UBEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ube Business Description

Other Exchanges 4208:JapanUBE:Germany
Address Seavans North Building, 1-2-1, Shibaura, Minato-Ku, Tokyo, JPN, 105-8449
Ube Corp manufactures and sells chemicals, construction materials, and machinery products. The firm organizes itself into five segments based on product type. The chemicals segment, which generates more revenue than any other segment, sells a variety of chemicals including resins, rubber, silicon, and plastics. The cement and construction segment sells cement, plaster, and foundation materials to the construction and building industries. The pharmaceutical segment sells anti-allergic, anti-hypertensive, and anti-platelet drugs. The machinery and metal products segment sells die-casting and electric injection machines. The energy and environment segment generates electricity from coal and biomass. The majority of revenue comes from Japan.
59GF Score

Get the complete analysis for UBEOF

Change In Payables And Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.29
Price
$11.18
GF Value